Novel Cellular Factors Restricting Viral Membrane Fusion
Novel Cellular Factors Restricting Viral Membrane Fusion
批准号:
8492736
负责人:
Shan-Lu Liu
金额:
$22.88万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-01-15 至 2014-12-31
关键词:
Academic Medical CentersAntiviral AgentsAntiviral TherapyBiological AssayBiologyCell Surface ProteinsCell fusionCell membraneCell physiologyCellsCollaborationsDevelopmentEndocytosisEventFUS-1 ProteinFamilyFertilizationFluorescenceFutureGenesGrowthHIV-1HemagglutininHumanIFITM1 geneImaging TechniquesInfectionInfluenzaInfluenza A virusIntegral Membrane ProteinInterferonsInvestigationLabelLeadLifeLipidsLiposomesMembraneMembrane FusionMolecularMorbidity - disease ratePeptidesPlayProcessRespiratory DiaphragmRoleRuptureSeriesStagingTestingTherapeuticTissuesVesicleViralViral Fusion ProteinsVirionVirusVirus Diseasesanalogdesignfluidityforestin vivoinsightlaurdanmembermortalitynovelparticlepreventpublic health relevancereconstitutionresearch studysynthetic peptidetomographyvesicular stomatitis virus G protein
中文摘要
描述(由申请人提供):在该R21申请中,我们旨在确定新鉴定的细胞限制因子(称为干扰素诱导跨膜(IFITM)蛋白)如何调节病毒膜融合和进入,并在此过程中帮助开发新型抗病毒治疗剂。这项建议的具体目标如下。 目的1:检验IFITM蛋白通过阻止半融合来抑制膜融合的假设。我们将进行细胞-细胞和病毒体-细胞融合试验,包括使用单病毒颗粒成像技术,以确定IFITM蛋白阻断的病毒膜融合过程的阶段。将应用调节膜融合过程的不同阶段的脂质类似物。我们将探讨IFITM蛋白限制细胞和发育融合因子诱导的膜融合的可能性。 目的2:检验IFITM蛋白表达改变细胞膜脂质顺序并赋予正自发曲率的假设。我们将进行荧光膜标记实验,以检验IFITM蛋白导致细胞膜更加有序,导致流动性降低,从而降低融合能力的假设。我们还将通过用与IFITM蛋白中的功能结构域对应的合成肽重构人工脂质体来确定IFITM蛋白对膜曲率的影响。将应用Cryo-EM断层扫描直接观察IFITM肽插入人工脂质体囊泡后的曲率变化。 IFITM蛋白是第一个也是迄今为止唯一一个已知限制病毒膜融合和进入的细胞限制因子。从拟议的研究结果将提供新的见解IFITM蛋白如何限制病毒膜融合。这些结果将指导未来对IFITM蛋白生物学的全面研究,以及它们的生物学特性。
在限制病毒进入和感染方面起着关键作用。
英文摘要
DESCRIPTION (provided by applicant): In this R21 application, we aim to determine how the newly identified cellular restriction factors, known as interferon-inducible transmembrane (IFITM) proteins, modulate viral membrane fusion and entry, and in doing so, aid the development of novel antiviral therapeutics. The specific aims of this proposal are as follows. Aim 1: Test the hypothesis that IFITM proteins inhibit membrane fusion by preventing hemifusion. We will perform cell-cell and virion-cell fusion assays, including the use of single viral particle imaging technique, to determine the stages of the viral membrane fusion process blocked by IFITM proteins. Lipid analogs that modulate distinct stages of the membrane fusion process will be applied. We will explore the possibility that IFITM proteins restrict membrane fusion induced by cellular and developmental fusogens. Aim 2: Test the hypothesis that expression of IFITM proteins changes the lipid order of cell membranes and confers positive spontaneous curvature. We will perform fluorescence membrane labeling experiments to test the hypothesis that IFITM proteins cause the cell membrane to be more ordered, resulting in reduced fluidity and therefore less competency for fusion. We will also determine the effect of IFITM proteins on membrane curvature by reconstituting artificial liposomes with synthetic peptides corresponding to the functional domains in IFITM proteins. Cryo-EM tomography will be applied to directly visualize the curvature changes upon insertion of IFITM peptides into the artificial liposome vesicles. IFITM proteins are the first and so far only cellular restriction fators that are known to restrict viral membrane fusion and entry. Results from the proposed studies will provide novel insight as to how IFITM proteins restrict viral membrane fusion. These results will guide future comprehensive investigations into the biology of IFITM proteins, as well as their
critical roles in restricting viral entry and infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TIM-mediated Inhibition of HIV Release: Cooperation with SERINC and Antagonism by Nef
-
批准号:10242695
-
项目类别:
-
资助金额:$33.15万
-
财政年份:2018
-
负责人:Shan-Lu Liu
-
依托单位:
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
-
批准号:9376203
-
项目类别:
-
资助金额:$36.3万
-
财政年份:2017
-
负责人:Shan-Lu Liu
-
依托单位:
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
-
批准号:8991472
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2014
-
负责人:Shan-Lu Liu
-
依托单位:
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
-
批准号:8730947
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2014
-
负责人:Shan-Lu Liu
-
依托单位:
Inhibition of Ebolavirus Entry by IFITM2 Protein
-
批准号:8702561
-
项目类别:
-
资助金额:$22.61万
-
财政年份:2014
-
负责人:Shan-Lu Liu
-
依托单位:
Restriction of Viral Membrane Fusion and Entry by IFITM Proteins
-
批准号:8896142
-
项目类别:
-
资助金额:$39.3万
-
财政年份:2014
-
负责人:Shan-Lu Liu
-
依托单位:
Novel Cellular Factors Restricting Viral Membrane Fusion
-
批准号:8605170
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2013
-
负责人:Shan-Lu Liu
-
依托单位:
海外基金